Jim Cramer Blog

Here are 7 trading ideas for today. This list comes directly from the TradingMarkets Stock Indicators page and is based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Taser International (NasdaqGS:TASR - News). TASR's PowerRating (for Traders) is 9.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Inverness Medical Technology (NYSE:IMA - News). IMA's PowerRating (for Traders) is 7.
Stocks Down 10% or More: These are stocks that have lost 10% or more over the past five days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that have lost 10% or more over the past five days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Amazon.com (NasdaqGS:AMZN - News) & Illumina (NasdaqGM:ILMN - News). AMZN's PowerRating (for Traders) is 6, and ILMN's PowerRating (for Traders) is 6.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Autozone (NYSE:AZO - News). AZO's PowerRating (for Traders) is 3.
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
JM Smucker (NYSE:SJM - News). SJM's PowerRating (for Traders) is 4.
Stocks Up 10% or More: These are stocks that have gained 10% or more over the past five days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that have gained 10% or more over the past five days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
Beazer Homes (NYSE:BZH - News). BZH's PowerRating (for Traders) is 3.
Published By TradingMarkets.com

Labels: AMZN, AZO, BZH, Hot Stocks, ILMN, IMA, SJM, TASR

Bullish calls:
PPG Industries (NYSE: PPG - News): 'I want you to pull the trigger on PPG ... Buy one half the position. Hope the market brings it down if there's no takeover, and I think you will make money.'Millicom International Cellular (NasdaqGS: MICC - News): ' ... ahead of the quarter, maybe don't pull the trigger. If it comes in - that has fabulous growth, as does AMX. I endorse it.'America Movil (NYSE: AMX - News)Nova Chemicals (NYSE: NCX - News)Rhodia (NYSE: RHA - News): ' ... these companies are just in bull market mode... You are in a really smart company. They do a lot of things right.'Inverness Medical (AMEX: IMA - News): 'This is the fastest-growing diagnostic stock in the world... It's made a great acquisition of Biosite, which is another Cramer fave... I say you buy and stick with IMA!'Intuitive Surgical (NasdaqGS: ISRG - News): ' ISRG, is still going higher! That's how good the quarter was. There are too many people who want in. Why don't you wait until Wednesday before you do any schnitzelling (i.e., selling some).'General Cable (NYSE: BGC - News): ' ... I say, who needs to rebuild pipes? Who needs to rebuild electric lines? Who gets those orders? In most of America, it is BGC .... Now we've been up 30 points ... after the Chinese selloff ... It's still a buy!'
Bearish calls:
Gemstar (NasdaqGS: GMST - News): 'No, no. It's putting itself for sale... No. Sell, sell, sell. We had a very nice gain. Let's not overstay our welcome.'Starbucks (NasdaqGS: SBUX - News): ' I think that SBUX is trying to bottom ... If they can possibly just stabilize the same-store sales, you're talking about a company that finally is growing ... it's dead money. And I'm not going to encourage you to sell it anymore ... but, don't buy, don't buy... I don't know the rumors at all.'Sara Lee (NYSE: SLE - News): 'SLE is not that good of a company ... I want you to take off a quarter of that stock. It's just dead money.'GigaMedia (NasdaqGM: GIGM - News): 'I don't see anything that I want that I want to pull the trigger on GIGM. I'm not going to plant it though. I'm just going to say 'don't buy...'Rio Tinto (NYSE: RTP - News): 'It's had a big run. It's making a lot of acquisitions... It's been terrific, but let's let it come in a little.'
Published by SeekingAlpha

Labels: AMX, BGC, GIGM, GMST, IMA, ISRG, Jim Cramer, Lightning Round, MICC, NCX, PPG, RHA, RTP, SBUX, SLE

Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Cephalon (NasdaqGS:CEPH - News). CEPH's PowerRating is 7.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Ruby Tuesday (NYSE:RI - News). RI's PowerRating is 7.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
LSI Corporation (NYSE:LSI - News) & Orient Express Hotels (NYSE:OEH - News). LSI's PowerRating is 7, and OEH's PowerRating is 7.
Stocks Down 10% or More: These are stocks that have lost 10% or more over the past five days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that have lost 10% or more over the past five days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Inverness Medical (NYSE:IMA - News). IMA's PowerRating is 7.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
Whiting Petroleum (NYSE:WLL - News). WLL's PowerRating is 4.
2-Period RSI Above 98: These are stocks that have a 2-period RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
Pfizer (NYSE:PFE - News). PFE's PowerRating is 4.
PowerRatings are courtesy of PowerRatings.net

Labels: CEPH, Hot Stocks, IMA, LSI, OEH, pfe, RI, WLL

Stocks traded aimlessly again today as investors waited for the start of earnings season, which traditionally kicks off with an announcement from aluminum producer Alcoa (NYSE: AA - News). The major market averages all managed to post modest gains. Oil prices were also higher, as was the 10-year Treasury note, which saw its yield drop to 4.72%.
Housing was once again in the spotlight as homebuilder D.R Horton (NYSE: DHI - News) announced that is Q2 sales orders fell 37% overall, paced by even steeper declines in the formerly booming California and the Southwest markets. The company's net orders totaled 9,983 homes, down from 15,771 homes last year. Horton's Q2 ended March 31st. The stock closed -1.5% lower.
In corporate news, Swedish telecom equipment maker LM Ericsson (Nasdaq: ERIC - News) signed a deal to manage a portion of the European network of Vodafone (NYSE: VOD - News). Ericsson's shares added 3.6% on the news. Citigroup (NYSE: C - News) was up 1.6% as investors waited for the results of its long-anticipated cost review. Generic drugmaker Mylan Laboratories (NYSE: MYL - News) rose 2.8% after it raised its 2007 profit forecast to a range of $1.60 to $1.63 a share, up from its previous guidance of $1.50 to $1.55 per share. Mylan cited strength in its generics business, including new product launches, for its upbeat forecast.
The flip side of the drug business was exemplified by biopharmaceutical company Adolor (Nasdaq: ADLR - News), which saw its shares plunge -58.7% after it announced that it stopped a study of a new drug to treat opioid-induced (OIC) constipation over safety concerns. The drug, Entereg, was being developed in association with British drugmaker GlaxoSmithKline (NYSE: GSK - News). Several analysts swiftly issued downgrades for Adolor, while Brean Murray Carret reiterated its "sell" recommendation. Progenics Pharmaceuticals (Nasdaq: PGNX - News), which submitted its own OIC compound for FDA approval last Friday along with partner Wyeth (NYSE: WYE - News), added 1.5% today.
Shares of ImClone Systems (Nasdaq: IMCL - News) also slid -6.4% on poor trial results. The company said a late-stage trial of its cancer drug Erbitux failed to extend survival in patients with pancreatic cancer. Erbitux is already approved for treatment of colorectal cancer, and head and neck cancer.
In M&A news, Biosite (Nasdaq: BSTE - News) said it will enter merger talks with Inverness Medical Innovations (NYSE: IMA - News), which last week offered $90 a share for the maker of medical diagnostic tests. IMA's bid topped an earlier offer from Beckman Coulter (NYSE: BEC - News) of $85. All three companies are in the business of making medical test products.

Labels: AA, ADLR, BEC, BSTE, C, DHI, ERIC, GSK, IMA, IMCL, MYL, PGNX, VOD, WYE

Stocks traded modestly higher to record their sixth-straight advance ahead of a three-day weekend. Despite the gains, there was little news to propel a stronger advance. One exception was DaimlerChrysler (NYSE: DCX - News), which gained 5.3% on a report that it had a cash offer on the table for its Chrysler unit. Oil prices declined slightly, and the 10-year Treasury note also closed lower.

The activity in DaimlerChrysler was spurred by a report in The Wall Street Journal that investor Kirk Kerkorian's Tracinda Corp. offered to buy Chrysler for $4.5 billion in cash. Kerkorian had been an active investor in Chrysler before it merged with Daimler Benz. He recently sold his 10% stake in General Motors (NYSE: GM - News), which gained 2.8% today.
Tech stocks came under some pressure early in the session after Micron Technology (NYSE: MU - News) posted a fiscal Q2 loss late Wednesday. The flash memory maker posted a loss of -$52 million for the quarter ended March 30th, or -7 cents per share, compared with a profit of $193 million, or 29 cents per share, last year. Wall Street expected the company to lose a penny a share. The stock traded down -4.6%, and Goldman Sachs advised clients to sell the stock.
Business software maker WebMethods (Nasdaq: WEBM - News) jumped 27.2% on news that it agreed to be acquired by Germany's Software AG. Shares of Constellation Brands (STZ, $21.49, 0.67), the world's biggest wine producer, rose 3.2% after the company reported its fiscal Q4 profit rose 21%. The company reported net income in the quarter ended February 28th of $70 million, or 29 cents a share, up from $58 million, or 24 cents a share, a year earlier. Strong wine sales offset a weak performance in Britain and a drop in beer imports in the U.S.
Shares of data storage maker Rackable Systems (Nasdaq: RACK - News) shed -15.6% to hit a 52-week low after the company issued reduced guidance for Q1. The company is now forecasting a loss. Caris & Co. reiterated a "sell" recommendation for Rackable Systems.
In other news, Vertex Pharmaceuticals (Nasdaq: VRTX - News) rose 3.6% in advance of what are expected to be favorable results from a clinical trial of the biotech company's hepatitis C drug Telaprevir. Medical diagnostic company Biosite (Nasdaq: BSTE - News) jumped 10.5% on news of an unsolicited $90-a-share purchase offer from Inverness Medical Innovations (NYSE: IMA - News). Beckman Coulter (NYSE: BEC - News), a maker of medical tests, put an $85-a-share offer on the table for Biosite in March. Inverness already owns 4.9% of Biosite's stock.

By the BullMarket.com Staff

Labels: BEC, BSTE, DCX, GM, IMA, MU, RACK, VRTX, WEBM

Cenveo Inc. (NYSE:CVO - News) shares rose 9.3% after the company agreed to acquire Cadmus Communications Corp. (NASDAQ:CDMS - News) for $24.75 a share in cash. The deal represents an acquisition premium of 18%. The total value of the transaction, including assumption of debt, is expected to be about $430 million, Cadmus said. A combined Cenveo and Cadmus would rank as the No. 3 graphics-communications company in North America with revenue of more than $2 billion, according to Stamford, Conn.-based Cenveo.
Crucell N.V. (NASDAQ:CRXL - News) shares climbed 2.2% after the company signed a cross-licensing agreement with Merck & Co, Inc. Under the deal, Merck will be allowed to use Crucell technology on an exclusive basis in undisclosed vaccine fields. In return Crucell will receive access to Merck's large-scale manufacturing technology for its AdVac-based malaria and TB vaccines.
InfoSonics' (NASDAQ:IFON - News) shares leapt 44% after the San Diego based-company said it has reached an agreement to distribute handsets for LG Electronics in the Caribbean and certain countries in Latin America. Financial terms of the deal weren't disclosed. InfoSonics said it has already received approval, certification and purchase orders from carriers in the region and will be delivering its first shipments in the coming weeks.
Inverness Medical Innovations (AMEX:IMA - News) shares rose 2.1% after the company formed a joint venture with Procter & Gamble (NYSE:PG - News) to develop, manufacture and market consumer diagnostic products outside of the fields of cardiology and diabetes. P&G will pay $325 million in cash for its 50% interest in the joint venture, the companies said. The deal is expected to close in the latter half of the first quarter of 2007, subject to regulatory approval and normal closing conditions.
Medwave Inc. (NASDAQ:MDWV - News) shares added 9.5% after the company named Ramon Burton as chief financial officer. Additionally, the Danvers, Mass.-based maker of blood pressure monitoring technology said it has appointed James Hawley to the board. Hawley, currently chief executive of Diversified Graphics Inc., will serve as chairman of the company's audit committee.
OxiGene Inc. (NASDAQ:OXGN - News) shares rose 5% after the Waltham, Mass.-based pharmaceutical company reported positive results from a Phase II study of combretastatin (CA4P) in combination with paclitaxel and carboplatin in patients with advanced imageable malignancies. Topline data indicate that the objectives of the study were met, the company said. The objectives were to identify optimal dose of CA4P for blood flow shutdown and to demonstrate safety and efficacy of CA4P in combination with paclitaxel and carboplatin.
PFSweb (NASDAQ:PFSW - News) shares jumped 18% after the Plano, Texas-based company said it has signed an agreement with Fathead LLC to provide order processing and fulfillment services. Financial terms of the deal were not disclosed. The agreement with Fathead was included in PFSweb's previously announced service fee contracts for the year, which will bring in estimated annual revenue of $12 million upon full implementation.
Sempra Energy (NYSE:SRE - News) shares rose 1.6% after the company said it expects 2006 earnings from continuing operations, excluding asset sales, to exceed $4 a share. The San Diego energy services holding company had previously forecast earnings between $3.50 and $3.70 a share. The company also said it will sell its interests in two Argentine natural-gas distribution companies.
Targacept (NASDAQ:TRGT - News) shares jumped 20% after the company said it's received confirmation from AstraZeneca (NYSE:AZN - News) of plans to continue development of AZD3480 in Alzheimer's disease and cognitive deficits in schizophrenia. The determination triggers a $20 million milestone payment to Targacept.
Vascular Solutions (NASDAQ:VASC - News) shares gained 17% after the company said the Food and Drug Administration has approved its premarket approval supplement for the D-Stat Flowable hemostat to reduce the incidence of clinically significant hematomas during the implantation of pacemakers or other devices.
By Michael Baron of Marketwatch

Labels: AZN, CDMS, CRXL, CVO, IFON, IMA, MDWV, OXGN, PFSW, PG, SRE, TRGT, VASC

Cenveo Inc. (NYSE:CVO - News) said it's reached a definitive agreement to acquire all outstanding stock of Cadmus Communications Corp. (NASDAQ:CDMS - News) for $24.75 a share in cash. The deal represents an acquisition premium of 18% over Tuesday's closing price of $20.98 on Cadmus shares. The total value of the transaction, including assumption of debt, is expected to be about $430 million, Cadmus said. A combined Cenveo and Cadmus would rank as the No. 3 graphics-communications company in North America with revenue of more than $2 billion, according to Stamford, Conn.-based Cenveo.
Crucell N.V. (NASDAQ:CRXL - News) signed a cross-licensing agreement with Merck & Co, Inc. . Under the deal, Merck will be allowed to use Crucell technology on an exclusive basis in undisclosed vaccine fields. In return Crucell will receive access to Merck's large-scale manufacturing technology for its AdVac-based malaria and TB vaccines.
HCC Insurance Holdings' (NYSE:HCC - News) shares rose after the company said it's completed an independent review of its stock option granting practice and recorded a gross non-cash compensation expense of $26.6 million related to corrections of errors in the years 1997 through and including 2005. The company stated the charge had no impact on its reported net revenue, cash or cash flow for the period but it did result in a net after-tax decrease in shareholders' equity of $3.3 million. Houston-based HCC said its conclusion of the review and subsequent completion of certain quarterly and annual financial filings with the Securities and Exchange Commission will have "cured any possible Event of Default" stemming from its failure to deliver the reports in a timely manner under the provisions of certain debt offerings. In addition, HCC posted earnings of $93.3 million, or 80 cents a share, for the third quarter, up from a year-ago profit of $7.4 million, or 7 cents a share. Last year's third quarter reflects the impact of hurricane-related losses and the effect of reinsurance commutations.
InfoSonics' (NASDAQ:IFON - News) shares gained after the San Diego based-company said it has reached an agreement to distribute handsets for LG Electronics in the Caribbean and certain countries in Latin America. Financial terms of the deal weren't disclosed. InfoSonics said it has already received approval, certification and purchase orders from carriers in the region and will be delivering its first shipments in the coming weeks.
Inverness Medical Innovations (AMEX:IMA - News) shares rose after the company formed a joinr venture with Procter & Gamble (NYSE:PG - News) to develop, manufacture and market consumer diagnostic products outside of the fields of cardiology and diabetes. P&G will pay $325 million in cash for its 50% interest in the joint venture, the companies said. The deal is expected to close in the latter half of the first quarter of 2007, subject to regulatory approval and normal closing conditions.
Monster Worldwide Inc. (NASDAQ:MNST - News) said its board has elected Philip Lochner Jr. as a director, effective immediately. Among other prior positions, Lochner has served as a commissioner with the Securities and Exchange Commission. Lochner will join the special committee investigating the company's historical stock-option practices, and serve on the committee addressing related civil litigation.
PFSweb (NASDAQ:PFSW - News) shares leapt after the Plano, Texas-based company said it has signed an agreement with Fathead LLC to provide order processing and fulfillment services. Financial terms of the deal were not disclosed. The agreement with Fathead was included in PFSweb's previously announced service fee contracts for the year, which will bring in estimated annual revenue of $12 million upon full implementation.
Sempra Energy (NYSE:SRE - News) said it expects 2006 earnings from continuing operations, excluding asset sales, to exceed $4 a share. The San Diego energy services holding company had previously forecast earnings between $3.50 and $3.70 a share. The company also said it will sell its interests in two Argentine natural-gas distribution companies.
Targacept (NASDAQ:TRGT - News) shares jumped after the company said it's received confirmation from AstraZeneca (NYSE:AZN - News) of plans to continue development of AZD3480 in Alzheimer's disease and cognitive deficits in schizophrenia. This determination triggers a $20 million milestone payment to Targacept.
Vascular Solutions (NASDAQ:VASC - News) said the Food and Drug Administration has approved its premarket approval supplement for the D-Stat Flowable hemostat to reduce the incidence of clinically significant hematomas during the implantation of pacemakers or other devices.
By Michael Baron of MarketWatch

Labels: AZN, CDMS, CRXL, CVO, HCC, IFON, IMA, MNST, PFSW, PG, SRE, TRGT, VASC

Cenveo Inc. (NYSE:CVO - News) said it's reached a definitive agreement to acquire all outstanding stock of Cadmus Communications Corp. (NASDAQ:CDMS - News) for $24.75 a share in cash. The deal represents an acquisition premium of 18% over Tuesday's closing price of $20.98 on Cadmus shares. The total value of the transaction, including assumption of debt, is expected to be about $430 million, Cadmus said. A combined Cenveo and Cadmus would rank as the No. 3 graphics-communications company in North America with revenue of more than $2 billion, according to Stamford, Conn.-based Cenveo.
Crucell N.V. (NASDAQ:CRXL - News) signed a cross-licensing agreement with Merck & Co, Inc. . Under the deal, Merck will be allowed to use Crucell technology on an exclusive basis in undisclosed vaccine fields. In return Crucell will receive access to Merck's large-scale manufacturing technology for its AdVac-based malaria and TB vaccines.
HCC Insurance Holdings' (NYSE:HCC - News) shares rose after the company said it's completed an independent review of its stock option granting practice and recorded a gross non-cash compensation expense of $26.6 million related to corrections of errors in the years 1997 through and including 2005. The company stated the charge had no impact on its reported net revenue, cash or cash flow for the period but it did result in a net after-tax decrease in shareholders' equity of $3.3 million. Houston-based HCC said its conclusion of the review and subsequent completion of certain quarterly and annual financial filings with the Securities and Exchange Commission will have "cured any possible Event of Default" stemming from its failure to deliver the reports in a timely manner under the provisions of certain debt offerings. In addition, HCC posted earnings of $93.3 million, or 80 cents a share, for the third quarter, up from a year-ago profit of $7.4 million, or 7 cents a share. Last year's third quarter reflects the impact of hurricane-related losses and the effect of reinsurance commutations.
InfoSonics' (NASDAQ:IFON - News) shares gained after the San Diego based-company said it has reached an agreement to distribute handsets for LG Electronics in the Caribbean and certain countries in Latin America. Financial terms of the deal weren't disclosed. InfoSonics said it has already received approval, certification and purchase orders from carriers in the region and will be delivering its first shipments in the coming weeks.
Inverness Medical Innovations (AMEX:IMA - News) shares rose after the company formed a joinr venture with Procter & Gamble (NYSE:PG - News) to develop, manufacture and market consumer diagnostic products outside of the fields of cardiology and diabetes. P&G will pay $325 million in cash for its 50% interest in the joint venture, the companies said. The deal is expected to close in the latter half of the first quarter of 2007, subject to regulatory approval and normal closing conditions.
Monster Worldwide Inc. (NASDAQ:MNST - News) said its board has elected Philip Lochner Jr. as a director, effective immediately. Among other prior positions, Lochner has served as a commissioner with the Securities and Exchange Commission. Lochner will join the special committee investigating the company's historical stock-option practices, and serve on the committee addressing related civil litigation.
PFSweb (NASDAQ:PFSW - News) shares leapt after the Plano, Texas-based company said it has signed an agreement with Fathead LLC to provide order processing and fulfillment services. Financial terms of the deal were not disclosed. The agreement with Fathead was included in PFSweb's previously announced service fee contracts for the year, which will bring in estimated annual revenue of $12 million upon full implementation.
Sempra Energy (NYSE:SRE - News) said it expects 2006 earnings from continuing operations, excluding asset sales, to exceed $4 a share. The San Diego energy services holding company had previously forecast earnings between $3.50 and $3.70 a share. The company also said it will sell its interests in two Argentine natural-gas distribution companies.
Targacept (NASDAQ:TRGT - News) shares jumped after the company said it's received confirmation from AstraZeneca (NYSE:AZN - News) of plans to continue development of AZD3480 in Alzheimer's disease and cognitive deficits in schizophrenia. This determination triggers a $20 million milestone payment to Targacept.
Vascular Solutions (NASDAQ:VASC - News) said the Food and Drug Administration has approved its premarket approval supplement for the D-Stat Flowable hemostat to reduce the incidence of clinically significant hematomas during the implantation of pacemakers or other devices.
By Michael Baron of MarketWatch

Labels: AZN, CDMS, CRXL, CVO, HCC, IFON, IMA, MNST, PFSW, PG, SRE, TRGT, VASC